Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

119.83
BATS BZX Real-Time Price
As of 2:52pm ET
 -0.64 / -0.53%
Today’s Change
96.18
Today|||52-Week Range
149.34
+0.20%
Year-to-Date

Today’s Trading

Previous close120.47
Today’s open120.29
Day’s range119.74 - 122.08
Volume59,492
Average volume (3 months)2,201,208
Market cap$26.7B
Data as of 2:52pm ET, 02/20/2018

Growth & Valuation

Earnings growth (last year)+11.93%
Earnings growth (this year)--
Earnings growth (next 5 years)+18.53%
Revenue growth (last year)+17.32%
P/E ratio61.1
Price/Sales7.63
Price/Book3.01

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+0.68+0.85%
BAXBaxter International...+0.62+0.93%
INCYIncyte Corp+0.29+0.34%
VRTXVertex Pharmaceutica...+1.62+1.01%
Data as of 2:52pm ET, 02/20/2018

Financials

Last reporting dateFebruary 8, 2018
EPS forecast (this quarter)$1.27
Annual revenue (last year)$3.5B
Annual profit (last year)$443.3M
Net profit margin12.55%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ludwig N. Hantson
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
New Haven, Connecticut

Forecasts